Showing results (181-190 of 198) with videos related to
Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|May 31, 2011
The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohortsLonneke V van de Poll-Franse, Nicole Horevoorts, Mies van Eenbergen, et al.Annals of Vascular Surgery|May 18, 2018
Quality of Life and Mortality after Endovascular, Surgical, or Conservative Treatment of Elderly Patients Suffering from Critical Limb IschemiaStijn L Steunenberg, Jolanda de Vries, Jelle W Raats, et al.European Journal of Gastroenterology & Hepatology|July 12, 2008
High prevalence of morphometric vertebral deformities in patients with inflammatory bowel diseaseAnna Caroline Heijckmann, Maya S P Huijberts, Erik J Schoon, et al.European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|September 11, 2007
The influence of myocardial scar and dyssynchrony on reverse remodeling in cardiac resynchronization therapyAnnemieke H M Jansen, Frank Bracke, Jan Melle van Dantzig, et al.Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 9, 2016
Validation of the King's Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis populationMirjam J G Van Manen, Monique Wapenaar, Bert Strookappe, et al.Cardiovascular and Interventional Radiology|June 10, 2022
Predictive Factors for Sustained Pain after (sub)acute Osteoporotic Vertebral Fractures. Combined Results from the VERTOS II and VERTOS IV TrialCristina E Firanescu, Alexander Venmans, Jolanda de Vries, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2014
Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanomaHenning Zelba, Benjamin Weide, Alexander Martens, et al.Cardiovascular and Interventional Radiology|April 4, 2019
Percutaneous Vertebroplasty is no Risk Factor for New Vertebral Fractures and Protects Against Further Height Loss (VERTOS IV)Cristina E Firanescu, Jolanda de Vries, Paul Lodder, et al.Diagnostics (Basel, Switzerland)|July 2, 2021
Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health OutcomesLesley Ann Saketkoo, Anne-Marie Russell, Kelly Jensen, et al.BMJ (Clinical Research Ed.)|May 11, 2018
Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trialCristina E Firanescu, Jolanda de Vries, Paul Lodder, et al.Pageof 20